Publication:
Role of Genetics and Epigenetics in Male Infertility

dc.authorscopusid6603432100
dc.authorscopusid57208580149
dc.contributor.authorGüneş, S.
dc.contributor.authorEsteves, S.C.
dc.date.accessioned2020-06-21T12:18:02Z
dc.date.available2020-06-21T12:18:02Z
dc.date.issued2021
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Güneş] Sezgin Özgür, Department of Medical Biology, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Molecular Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Esteves] Sandro C., Andrology and Human Reproduction Clinic, ANDROFERT, Campinas, SP, Brazil, Department of Surgery (Division of Urology), Universidade Estadual de Campinas, Campinas, SP, Brazil, Fakultetet Health, Aarhus, Midtjylland, Denmarken_US
dc.description.abstractMale infertility is a complex condition with a strong genetic and epigenetic background. This review discusses the importance of genetic and epigenetic factors in the pathophysiology of male infertility. The interplay between thousands of genes, the epigenetic control of gene expression, and environmental and lifestyle factors, which influence genetic and epigenetic variants, determines the resulting male infertility phenotype. Currently, karyotyping, Y-chromosome microdeletion screening and CFTR gene mutation tests are routinely performed to investigate a possible genetic aetiology in patients with azoospermia and severe oligozoospermia. However, current testing is limited in its ability to identify a variety of genetic and epigenetic conditions that might be implicated in both idiopathic and unexplained infertility. Several epimutations of imprinting genes and developmental genes have been postulated to be candidate markers for male infertility. As such, development of novel diagnostic panels is essential to change the current landscape with regard to prevention, diagnosis and management. Understanding the underlying genetic mechanisms related to the pathophysiology of male infertility, and the impact of environmental exposures and lifestyle factors on gene expression might aid clinicians in developing individualised treatment strategies. © 2020 Blackwell Verlag GmbHen_US
dc.identifier.doi10.1111/and.13586
dc.identifier.issn0303-4569
dc.identifier.issn1439-0272
dc.identifier.issue1en_US
dc.identifier.pmid32314821
dc.identifier.scopus2-s2.0-85083646187
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1111/and.13586
dc.identifier.volume53en_US
dc.identifier.wosWOS:000527042200001
dc.identifier.wosqualityQ3
dc.language.isoenen_US
dc.publisherBlackwell Publishing Ltden_US
dc.relation.ispartofAndrologiaen_US
dc.relation.journalAndrologiaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectEpigeneticsen_US
dc.subjectEpigenomeen_US
dc.subjectGeneticsen_US
dc.subjectGenomeen_US
dc.subjectMale Infertilityen_US
dc.titleRole of Genetics and Epigenetics in Male Infertilityen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files